NMPA Approval

Sulfadiazine Sodium Injection

Approval Number

国药准字H46020166

Company海南制药厂有限公司

Registration Date

September 29, 2020

Drug Information

Generic Name

磺胺嘧啶钠注射液

Dosage Form

注射剂

Strength

2ml:0.4g

Drug Type

化学药品

Registration Date

September 29, 2020

Company Information

Applicant Company

Company Name海南制药厂有限公司

Company Address

海南省五指山市河北西路

Manufacturing Company

Company Name海南制药厂有限公司

Company Address

海南省五指山市河北西路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

磺胺嘧啶钠注射液 - NMPA 批准文号 | MedPath